These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

174 related items for PubMed ID: 10464846

  • 1. A comparison of two long-acting beta-agonists, oral bambuterol and inhaled salmeterol, in the treatment of moderate to severe asthmatic patients with nocturnal symptoms. The French Bambuterol Study Group.
    Wallaert B, Brun P, Ostinelli J, Murciano D, Champel F, Blaive B, Montané F, Godard P.
    Respir Med; 1999 Jan; 93(1):33-8. PubMed ID: 10464846
    [Abstract] [Full Text] [Related]

  • 2. Comparison of oral bambuterol and inhaled salmeterol in patients with symptomatic asthma and using inhaled corticosteroids.
    Crompton GK, Ayres JG, Basran G, Schiraldi G, Brusasco V, Eivindson A, Jamieson AH, Olsson H.
    Am J Respir Crit Care Med; 1999 Mar; 159(3):824-8. PubMed ID: 10051257
    [Abstract] [Full Text] [Related]

  • 3. Salmeterol xinafoate as maintenance therapy compared with albuterol in patients with asthma.
    D'Alonzo GE, Nathan RA, Henochowicz S, Morris RJ, Ratner P, Rennard SI.
    JAMA; 1994 May 11; 271(18):1412-6. PubMed ID: 7909853
    [Abstract] [Full Text] [Related]

  • 4. Comparison of the efficacy, tolerability and patient acceptability of once-daily bambuterol tablets against twice-daily controlled release salbutamol in nocturnal asthma. ACROBATICS Research Group.
    Gunn SD, Ayres JG, McConchie SM.
    Eur J Clin Pharmacol; 1995 May 11; 48(1):23-8. PubMed ID: 7621843
    [Abstract] [Full Text] [Related]

  • 5. Salmeterol compared with slow-release terbutaline in nocturnal asthma. A multicenter, randomized, double-blind, double-dummy, sequential clinical trial. French Multicenter Study Group.
    Brambilla C, Chastang C, Georges D, Bertin L.
    Allergy; 1994 Jul 11; 49(6):421-6. PubMed ID: 7915501
    [Abstract] [Full Text] [Related]

  • 6. Salmeterol xinafoate in asthmatic patients under consideration for maintenance oral corticosteroid therapy. UK Study Group.
    Boyd G.
    Eur Respir J; 1995 Sep 11; 8(9):1494-8. PubMed ID: 8575574
    [Abstract] [Full Text] [Related]

  • 7. Salmeterol in nocturnal asthma: a double blind, placebo controlled trial of a long acting inhaled beta 2 agonist.
    Fitzpatrick MF, Mackay T, Driver H, Douglas NJ.
    BMJ; 1990 Dec 15; 301(6765):1365-8. PubMed ID: 1980220
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Comparison of inhaled salmeterol and oral zafirlukast in patients with asthma.
    Busse W, Nelson H, Wolfe J, Kalberg C, Yancey SW, Rickard KA.
    J Allergy Clin Immunol; 1999 Jun 15; 103(6):1075-80. PubMed ID: 10359889
    [Abstract] [Full Text] [Related]

  • 12. Comparative study using oral solutions of bambuterol once daily or terbutaline three times daily in 2-5-year-old children with asthma. Bambuterol Multicentre Study Group.
    Kuusela AL, Marenk M, Sandahl G, Sanderud J, Nikolajev K, Persson B.
    Pediatr Pulmonol; 2000 Mar 15; 29(3):194-201. PubMed ID: 10686040
    [Abstract] [Full Text] [Related]

  • 13. A 4-week comparison of salmeterol and terbutaline in adult asthma.
    Hermansson BA, Jenkins RJ.
    Allergy; 1995 Jul 15; 50(7):551-8. PubMed ID: 8588686
    [Abstract] [Full Text] [Related]

  • 14. Comparison of inhaled salmeterol and oral zafirlukast in asthmatic patients using concomitant inhaled corticosteroids.
    Nelson HS, Nathan RA, Kalberg C, Yancey SW, Rickard KA.
    MedGenMed; 2001 Jul 05; 3(4):3. PubMed ID: 11549982
    [Abstract] [Full Text] [Related]

  • 15. One month treatment with the once daily oral beta 2-agonist bambuterol in asthmatic patients.
    Persson G, Baas A, Knight A, Larsen B, Olsson H.
    Eur Respir J; 1995 Jan 05; 8(1):34-9. PubMed ID: 7744191
    [Abstract] [Full Text] [Related]

  • 16. Comparison of salmeterol with beclomethasone in adult patients with mild persistent asthma who are already on low-dose inhaled steroids.
    Vermetten FA, Boermans AJ, Luiten WD, Mulder PG, Vermue NA.
    J Asthma; 1999 Jan 05; 36(1):97-106. PubMed ID: 10077139
    [Abstract] [Full Text] [Related]

  • 17. Effect of long-term salmeterol therapy compared with as-needed albuterol use on airway hyperresponsiveness.
    Rosenthal RR, Busse WW, Kemp JP, Baker JW, Kalberg C, Emmett A, Rickard KA.
    Chest; 1999 Sep 05; 116(3):595-602. PubMed ID: 10492259
    [Abstract] [Full Text] [Related]

  • 18. Inhaled salmeterol and albuterol in asthmatic patients receiving high-dose inhaled corticosteroids.
    Lai CK, Chan CH, Ho SS, Hui AC, Lai KN.
    Chest; 1995 Jul 05; 108(1):36-40. PubMed ID: 7606988
    [Abstract] [Full Text] [Related]

  • 19. Salmeterol, a new long acting inhaled beta 2 adrenoceptor agonist: comparison with salbutamol in adult asthmatic patients.
    Ullman A, Svedmyr N.
    Thorax; 1988 Sep 05; 43(9):674-8. PubMed ID: 2904183
    [Abstract] [Full Text] [Related]

  • 20. Salmeterol powder provides significantly better benefit than montelukast in asthmatic patients receiving concomitant inhaled corticosteroid therapy.
    Fish JE, Israel E, Murray JJ, Emmett A, Boone R, Yancey SW, Rickard KA.
    Chest; 2001 Aug 05; 120(2):423-30. PubMed ID: 11502639
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.